医学理论与实践
醫學理論與實踐
의학이론여실천
The Journal of Medical Theory and Practice
2015年
16期
2133-2134,2151
,共3页
2型糖尿病%二甲双胍%利拉鲁肽
2型糖尿病%二甲雙胍%利拉魯肽
2형당뇨병%이갑쌍고%리랍로태
Type 2 diabetes mellitus%Metformin%Liraglutide
目的:观察存在胰岛素抵抗的2型糖尿病患者采用单纯口服二甲双胍治疗及其与利拉鲁肽联合治疗对患者血糖、GA、HbA1c、体重控制及胰岛素抵抗的影响.方法:2型糖尿病伴胰岛素抵抗患者174例 ,98例给予口服二甲双胍治疗(单药治疗组) ,76例给予口服二甲双胍与皮下注射利拉鲁肽联合治疗(联合治疗组) ,2周后比较空腹血糖、餐后血糖、GA的变化 ,12周后比较HbA1c变化情况、体重下降情况及胰岛素抵抗改善情况.结果:两组血糖、GA、HbA1c较治疗前均下降(P<0 .05).联合治疗组短期及长期血糖控制效果优于单药治疗组(P<0 .05) ,联合治疗组体重下降水平优于单药治疗组(P<0 .05) ,联合治疗组胰岛素抵抗改善程度优于单药治疗组(P<0 .05) ,两组低血糖发生率无统计学差异.结论:对于2型糖尿病合并胰岛素抵抗患者早期联合应用二甲双胍和利拉鲁肽可以更好地控制血糖 ,改善胰岛素抵抗 ,不增加低血糖发生率.
目的:觀察存在胰島素牴抗的2型糖尿病患者採用單純口服二甲雙胍治療及其與利拉魯肽聯閤治療對患者血糖、GA、HbA1c、體重控製及胰島素牴抗的影響.方法:2型糖尿病伴胰島素牴抗患者174例 ,98例給予口服二甲雙胍治療(單藥治療組) ,76例給予口服二甲雙胍與皮下註射利拉魯肽聯閤治療(聯閤治療組) ,2週後比較空腹血糖、餐後血糖、GA的變化 ,12週後比較HbA1c變化情況、體重下降情況及胰島素牴抗改善情況.結果:兩組血糖、GA、HbA1c較治療前均下降(P<0 .05).聯閤治療組短期及長期血糖控製效果優于單藥治療組(P<0 .05) ,聯閤治療組體重下降水平優于單藥治療組(P<0 .05) ,聯閤治療組胰島素牴抗改善程度優于單藥治療組(P<0 .05) ,兩組低血糖髮生率無統計學差異.結論:對于2型糖尿病閤併胰島素牴抗患者早期聯閤應用二甲雙胍和利拉魯肽可以更好地控製血糖 ,改善胰島素牴抗 ,不增加低血糖髮生率.
목적:관찰존재이도소저항적2형당뇨병환자채용단순구복이갑쌍고치료급기여리랍로태연합치료대환자혈당、GA、HbA1c、체중공제급이도소저항적영향.방법:2형당뇨병반이도소저항환자174례 ,98례급여구복이갑쌍고치료(단약치료조) ,76례급여구복이갑쌍고여피하주사리랍로태연합치료(연합치료조) ,2주후비교공복혈당、찬후혈당、GA적변화 ,12주후비교HbA1c변화정황、체중하강정황급이도소저항개선정황.결과:량조혈당、GA、HbA1c교치료전균하강(P<0 .05).연합치료조단기급장기혈당공제효과우우단약치료조(P<0 .05) ,연합치료조체중하강수평우우단약치료조(P<0 .05) ,연합치료조이도소저항개선정도우우단약치료조(P<0 .05) ,량조저혈당발생솔무통계학차이.결론:대우2형당뇨병합병이도소저항환자조기연합응용이갑쌍고화리랍로태가이경호지공제혈당 ,개선이도소저항 ,불증가저혈당발생솔.
Objective:To observe the effect of metformin therapy alone and metformin combined with liraglutide thera-py on glycemic control ,glycosylated serum albumin(GA) ,glycosylated hemoglobin (HbA1c) ,weight control and insu-lin resistance in type 2 diabetic patients with insulin resistance .Methods:174 type 2 diabetic patients with insulin resist-ance were enrolled .98 patients were treated with oral metformin treatment .76 patients were treated with oral metform-in combined with liraglutide therapy .The effect of blood glucose control and GA was compared between the two groups after 2 weeks .The effect of HbA1c ,weight control and insulin resistance was compared between the two groups after 12 weeks .Results:Blood sugar ,GA and HbA1c in two groups reduced after therapy(P<0 .05) .Short term and long-term glucose control ,level of weight control and insulin resistance improvement in metformin combined with liraglutide treatment group decreased better than metformin treatment group(P<0 .05) .There was no significant difference in in-cidence of hypoglycemia between the two groups .Conclusion:Early application of metformin and liraglutide in type 2 di-abetic patients with insulin resistance can better control blood glucose ,improve insulin resistance and don't increase the risk of hypoglycemia .